506 related articles for article (PubMed ID: 27980130)
1. Insulinotropic effects of GPR120 agonists are altered in obese diabetic and obese non-diabetic states.
Zhang D; So WY; Wang Y; Wu SY; Cheng Q; Leung PS
Clin Sci (Lond); 2017 Feb; 131(3):247-260. PubMed ID: 27980130
[TBL] [Abstract][Full Text] [Related]
2. GPR120 protects lipotoxicity-induced pancreatic β-cell dysfunction through regulation of PDX1 expression and inhibition of islet inflammation.
Wang Y; Xie T; Zhang D; Leung PS
Clin Sci (Lond); 2019 Jan; 133(1):101-116. PubMed ID: 30523046
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the insulin-releasing and glucose-lowering effects of GPR120 activation in pancreatic β-cells.
Moran BM; Abdel-Wahab YH; Flatt PR; McKillop AM
Diabetes Obes Metab; 2014 Nov; 16(11):1128-39. PubMed ID: 24919766
[TBL] [Abstract][Full Text] [Related]
4. PPAR-γ activation increases insulin secretion through the up-regulation of the free fatty acid receptor GPR40 in pancreatic β-cells.
Kim HS; Hwang YC; Koo SH; Park KS; Lee MS; Kim KW; Lee MK
PLoS One; 2013; 8(1):e50128. PubMed ID: 23372643
[TBL] [Abstract][Full Text] [Related]
5. Free fatty acid receptor 4 inhibitory signaling in delta cells regulates islet hormone secretion in mice.
Croze ML; Flisher MF; Guillaume A; Tremblay C; Noguchi GM; Granziera S; Vivot K; Castillo VC; Campbell SA; Ghislain J; Huising MO; Poitout V
Mol Metab; 2021 Mar; 45():101166. PubMed ID: 33484949
[TBL] [Abstract][Full Text] [Related]
6. Niacin-induced hyperglycemia is partially mediated via niacin receptor GPR109a in pancreatic islets.
Chen L; So WY; Li SY; Cheng Q; Boucher BJ; Leung PS
Mol Cell Endocrinol; 2015 Mar; 404():56-66. PubMed ID: 25622782
[TBL] [Abstract][Full Text] [Related]
7. Alteration of the glucagon axis in GPR120 (FFAR4) knockout mice: a role for GPR120 in glucagon secretion.
Suckow AT; Polidori D; Yan W; Chon S; Ma JY; Leonard J; Briscoe CP
J Biol Chem; 2014 May; 289(22):15751-63. PubMed ID: 24742677
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological potential of novel agonists for FFAR4 on islet and enteroendocrine cell function and glucose homeostasis.
McCloskey AG; Miskelly MG; Flatt PR; McKillop AM
Eur J Pharm Sci; 2020 Jan; 142():105104. PubMed ID: 31669388
[TBL] [Abstract][Full Text] [Related]
9. TAK-875, an orally available G protein-coupled receptor 40/free fatty acid receptor 1 agonist, enhances glucose-dependent insulin secretion and improves both postprandial and fasting hyperglycemia in type 2 diabetic rats.
Tsujihata Y; Ito R; Suzuki M; Harada A; Negoro N; Yasuma T; Momose Y; Takeuchi K
J Pharmacol Exp Ther; 2011 Oct; 339(1):228-37. PubMed ID: 21752941
[TBL] [Abstract][Full Text] [Related]
10. Irisin Ameliorates Glucolipotoxicity-Associated β-Cell Dysfunction and Apoptosis via AMPK Signaling and Anti-Inflammatory Actions.
Zhang D; Xie T; Leung PS
Cell Physiol Biochem; 2018; 51(2):924-937. PubMed ID: 30466091
[TBL] [Abstract][Full Text] [Related]
11. GPR120 Regulates Pancreatic Polypeptide Secretion From Male Mouse Islets via PLC-Mediated Calcium Mobilization.
Zhao YF; Li XC; Liang XY; Zhao YY; Xie R; Zhang LJ; Zhang XC; Chen C
Endocrinology; 2020 Oct; 161(10):. PubMed ID: 32877513
[TBL] [Abstract][Full Text] [Related]
12. GPR120 agonists for the treatment of diabetes: a patent review (2014 present).
Zhang X; Macielag MJ
Expert Opin Ther Pat; 2020 Oct; 30(10):729-742. PubMed ID: 32799609
[TBL] [Abstract][Full Text] [Related]
13. CNX-011-67, a novel GPR40 agonist, enhances glucose responsiveness, insulin secretion and islet insulin content in n-STZ rats and in islets from type 2 diabetic patients.
Sunil V; Verma MK; Oommen AM; Sadasivuni M; Singh J; Vijayraghav DN; Chandravanshi B; Shetty J; Biswas S; Dandu A; Moolemath Y; Venkataranganna MV; Somesh BP; Jagannath MR
BMC Pharmacol Toxicol; 2014 Mar; 15():19. PubMed ID: 24666736
[TBL] [Abstract][Full Text] [Related]
14. Expression of fatty acid binding proteins 3 and 5 genes in rat pancreatic islets and INS-1E cells: regulation by fatty acids and glucose.
Hyder A; Zenhom M; Klapper M; Herrmann J; Schrezenmeir J
Islets; 2010; 2(3):174-84. PubMed ID: 21099311
[TBL] [Abstract][Full Text] [Related]
15. GPR40 protein levels are crucial to the regulation of stimulated hormone secretion in pancreatic islets. Lessons from spontaneous obesity-prone and non-obese type 2 diabetes in rats.
Meidute Abaraviciene S; Muhammed SJ; Amisten S; Lundquist I; Salehi A
Mol Cell Endocrinol; 2013 Dec; 381(1-2):150-9. PubMed ID: 23911664
[TBL] [Abstract][Full Text] [Related]
16. Activation of extracellular signal-regulated protein kinases 1 and 2 (ERK1/2) by free fatty acid receptor 1 (FFAR1/GPR40) protects from palmitate-induced beta cell death, but plays no role in insulin secretion.
Panse M; Gerst F; Kaiser G; Teutsch CA; Dölker R; Wagner R; Häring HU; Ullrich S
Cell Physiol Biochem; 2015; 35(4):1537-45. PubMed ID: 25792236
[TBL] [Abstract][Full Text] [Related]
17. Selective small-molecule agonists of G protein-coupled receptor 40 promote glucose-dependent insulin secretion and reduce blood glucose in mice.
Tan CP; Feng Y; Zhou YP; Eiermann GJ; Petrov A; Zhou C; Lin S; Salituro G; Meinke P; Mosley R; Akiyama TE; Einstein M; Kumar S; Berger JP; Mills SG; Thornberry NA; Yang L; Howard AD
Diabetes; 2008 Aug; 57(8):2211-9. PubMed ID: 18477808
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Exposure of Pancreatic β-Cells to Palmitate Results in SREBP-1C-Dependent Decreases in GLP-1 Receptor Signaling via CREB and AKT and Insulin Secretory Response.
Natalicchio A; Biondi G; Marrano N; Labarbuta R; Tortosa F; Spagnuolo R; D'Oria R; Carchia E; Leonardini A; Cignarelli A; Perrini S; Laviola L; Giorgino F
Endocrinology; 2016 Jun; 157(6):2243-58. PubMed ID: 27035653
[TBL] [Abstract][Full Text] [Related]
19. Activated PPARβ/δ Protects Pancreatic β Cells in Type 2 Diabetic Goto-Kakizaki Rats from Lipoapoptosis via GPR40.
Li J; Xu S; Liu Y; Yan Z; Zhang F; Lv Q; Tong N
Lipids; 2019 Oct; 54(10):603-616. PubMed ID: 31364177
[TBL] [Abstract][Full Text] [Related]
20. Non-invasive imaging of ferucarbotran labeled INS-1E cells and rodent islets in vitro and in transplanted diabetic rats.
Auer VJ; Bucher J; Schremmer-Danninger E; Paulmurugan R; Maechler P; Reiser MF; Stangl MJ; Berger F
Curr Pharm Biotechnol; 2011 Apr; 12(4):488-96. PubMed ID: 21342106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
